| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $2,272,653 | 1 | 100 |
Sells | $0 | 0 | 0 |
| Wang Ching-Dong | Chief Executive Officer | 1 | $2.27M | 0 | $0 | $2.27M |
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company’s products include SL bio’s milk-derived exosome essence, SL bio’s tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026. The company is based in Taipei, Taiwan.
Over the last 12 months, insiders at SL Science Holding Ltd have bought $2.27M and sold $0 worth of SL Science Holding Ltd stock.
On average, over the past 5 years, insiders at SL Science Holding Ltd have bought $2.27M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Wang Ching-Dong (Chief Executive Officer) — $2.27M.
The last purchase of 4,545,306 shares for transaction amount of $2.27M was made by Wang Ching-Dong (Chief Executive Officer) on 2026‑09‑29.
| 2026-09-29 | Wang Ching-Dong | Chief Executive Officer | 4.55M 0.2215% | $0.50 | $2.27M | -17.49% |
| Increased Positions | 0 | 0% | 0 | 0% |
| Decreased Positions | 0 | 0% | 0 | 0% |
| New Positions | 0 | New | 0 | New |
| Sold Out Positions | 0 | Sold Out | 0 | Sold Out |
| Total Postitions | 0 | 0% | 0 | 0% |